Latest topics | Infection Update

LATEST TOPICS

First malaria saliva test identifies malaria parasites

Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were reported in 2017 –...

Researchers have developed a non-invasive, easy-to-use saliva test to screen for malaria parasites before patients present any clinical symptoms. An estimated 219 million malaria cases were reported in 2017 –...

Oral levofloxacin and intravenous vancomycin for bacteraemia due to Microbacterium paraoxydans

A patient with bacteraemia associated with a long-term central venous catheter (CVC) due to Microbacterium paraoxydans responded well to replacement of CVC, and treatment with oral levofloxacin and intravenous vancomycin....

A patient with bacteraemia associated with a long-term central venous catheter (CVC) due to Microbacterium paraoxydans responded well to replacement of CVC, and treatment with oral levofloxacin and intravenous vancomycin....

Levofloxacin for lower lobe pneumonia presenting as persistent hiccups

Levofloxacin has been shown to resolve a case of community-acquired pneumonia in an elderly patient presenting with persistent hiccups – without any typical symptoms, signs, or laboratory findings of pneumonia....

Levofloxacin has been shown to resolve a case of community-acquired pneumonia in an elderly patient presenting with persistent hiccups – without any typical symptoms, signs, or laboratory findings of pneumonia....

2018 Taiwan’s pneumonia guidelines: What’s new?

Dr Susan Shin-Jung Lee, MD, PhD Associate Professor, National Yang Ming University, Taipei, Taiwan. Chief, Division of Infectious Diseases, Department of Internal Medicine; Chief, Division of Microbiology, Department of Pathology...

Dr Susan Shin-Jung Lee, MD, PhD Associate Professor, National Yang Ming University, Taipei, Taiwan. Chief, Division of Infectious Diseases, Department of Internal Medicine; Chief, Division of Microbiology, Department of Pathology...

Progress against malaria stalls

28 February, 2019

Despite the falling number of malaria cases globally from 2010 to 2015, the numbers have been plateauing for the second consecutive year – with 217 million cases in 2016 and...

Despite the falling number of malaria cases globally from 2010 to 2015, the numbers have been plateauing for the second consecutive year – with 217 million cases in 2016 and...

Oral sitafloxacin as a switch therapy for the treatment of non-bacteraemic acute pyelonephritis

21 February, 2019

A treatment regimen of carbapenem followed by sitafloxacin or ertapenem was found to be effective in patients with non-bacteraemic acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC). The incidence...

A treatment regimen of carbapenem followed by sitafloxacin or ertapenem was found to be effective in patients with non-bacteraemic acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC). The incidence...

Managing mycobacterial infection after lung transplantation with levofloxacin: Case series

11 February, 2019

The combination of levofloxacin with isoniazid, pyrazinamide and ethambutol was found to be effective in managing mycobacterial infection in lung transplant recipients. The risk of mycobacterial infection is high for...

The combination of levofloxacin with isoniazid, pyrazinamide and ethambutol was found to be effective in managing mycobacterial infection in lung transplant recipients. The risk of mycobacterial infection is high for...

Can India eliminate TB by 2025?

25 January, 2019

India accounts for 27% of the estimated 10 million tuberculosis (TB) cases worldwide, and 26% of the 6.4 million new cases of TB reported in 2017 – making it one...

India accounts for 27% of the estimated 10 million tuberculosis (TB) cases worldwide, and 26% of the 6.4 million new cases of TB reported in 2017 – making it one...

Levofloxacin improves spondylitis complication in Escherichia coli endocarditis

18 January, 2019

A two-month course of levofloxacin (500 mg/day) resolved purulent spondylitis in a patient with Escherichia coli infective endocarditis (IE). A 58-year old Japanese woman presented with febrile illness, malaise, and...

A two-month course of levofloxacin (500 mg/day) resolved purulent spondylitis in a patient with Escherichia coli infective endocarditis (IE). A 58-year old Japanese woman presented with febrile illness, malaise, and...

Ceftriaxone plus levofloxacin for the treatment of Streptococcus intermedius pleuropulmonary infection

11 January, 2019

Ceftriaxone–levofloxacin combination is the most frequently used antimicrobial for the treatment of Streptococcus intermedius pleuropulmonary infection; drainage of pleural effusion and other surgical procedures such as pleurectomy, thoracotomy, decortication, and...

Ceftriaxone–levofloxacin combination is the most frequently used antimicrobial for the treatment of Streptococcus intermedius pleuropulmonary infection; drainage of pleural effusion and other surgical procedures such as pleurectomy, thoracotomy, decortication, and...

POPULAR ARTICLES